New diabetes pill tested for safety and sugar control
NCT ID NCT00707954
Summary
This early-stage study tested a new oral medication called TA-7284 for people with type 2 diabetes. Researchers gave 61 participants increasing doses of the drug over 15 days to check its safety and how the body processes it. The main goal was to see if the medication was well-tolerated and how it affected blood sugar levels.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TYPE 2 DIABETES MELLITUS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
P-One Clinic
Hachiōji, Tokyo-to, Japan
Conditions
Explore the condition pages connected to this study.